Can cellular transplantation improve function in doxorubicin-induced heart failure?

Circulation

Volumn 98, Issue 19 SUPPL., 1998, Pages

  Scorsin, Marcio ^b   Hagege, Albert A ^b   Dolizy, Isabelle ^b   Marotte, Françoise ^b   Mirochnik, Nicolas ^b   Copin, Henri ^b   Barnoux, Muriel ^b   Le Bert, Marc ^b   Samuel, Jane Lise ^b   Rappaport, Lydie ^b   Menasché, Philippe ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

^b NONE

Author keywords

Cells; Heart failure; Transplantation

Indexed keywords

BETA GALACTOSIDASE; DOXORUBICIN;

ANIMAL CELL; ARTICLE; CELL FUNCTION; CELL TRANSPLANTATION; CELL VIABILITY; DRUG INDUCED DISEASE; ENZYME ACTIVITY; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CELL; HEART PROTECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSTHORACIC ECHOCARDIOGRAPHY;

ANIMALS; CARDIAC OUTPUT, LOW; CELL TRANSPLANTATION; DOXORUBICIN; ECHOCARDIOGRAPHY; FEMALE; FETAL TISSUE TRANSPLANTATION; HEART; MICE; MYOCARDIUM; TIME FACTORS;

EID: 0345164449     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Mauro A. Satellite cell of skeletal muscle fiber. J Biophys Biochem Cytol. 1961;9:493-495.
2. Salmons S, Jarvis JC. The working capacity of skeletal muscle transformed for use in a cardiac assist role. In: Chiu RC-J, Bourgeois I, eds. Transformed Muscle for Cardiac Assist and Repair. New York, NY: Futura Publishing Co; 1990:89-104.
3. Scorsin M, Hagege A, Marotte F, Mirochnik N, Copin H, Barnoux M, Sabri A, Samuel J-L, Rappaport L, Menasche P. Does transplantation of cardiomyocytes improve function of infarcted myocardium? Circulation 1997;96(suppl II):II-188-II-193.
4. Li R-K, Jia Z-Q, Weisel RD, Mickle DAG, Zhang J, Mohabeer MK, Rao V, Ivanov J. Cardiomyocyte transplantation improves heart function. Ann Thorac Surg. 1996;62:654-661.
5. Sahn D, DeMaria A, Kisslo J, Weyman A. For the committee on M-mode standardization of the American Society of Echocardiography. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic methods. Circulation. 1978;58: 1072-1083.
6. Bland MJ, Altman DG. Statistical method for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307-310.
7. Fletcher P, Pfeffer J, Pfeffer M, Braunwald E. Left ventricular diastolic pressure-volume relations in rats with healed myocardial infarction. Circ Res. 1981;49:618-626.
8. Steinherz L, Graham T, Hurwitz R, Sondheimer H, Schwanz R, Schaffer E. Sandor G, Benson L, Williams R. Guidelines for cardiac monitoring of children during and after anthracycline therapy: report of the cardiology committee of the children's cancer study group. Pediatrics. 1992;89: 942-949.
9. Keren A, Popp R. Assignment of patients into the classification of cardiomyopathies. Circulation. 1992;86:1622-1633.
10. Grossman W. Cardiac hypertrophy: useful adaptation or pathologic process? Am J Med. 1980;69:576-584.
11. Billingham M. Pharmacotoxic myocardial disease: an endomyocardial study. In: Sekigushi M, Olsen-E, Goodwin J, eds. Myocardites and Related Disorders. Tokyo, Japan: Springer-Verlag; 1985;278-282.
12. Bottone A, de-Beer E, Voest E. Anthracyclines enhance tension development in cardiac muscle by direct interaction with contractile system. J Mol Cell Cardiol. 1997;29:1001-1008.
13. Bertazzoli C, Bellini O, Magrini U, Tosana M. Quantitative experimental evaluation of adriamycin cardiotoxicity in the mouse. Cancer Treat Rep. 1979;63:1877-1883.
14. Gardin J, Siri F, Kitsis R, Edwards J, Leinwand L. Echocardiographic assessment of left ventricular mass and systolic function in mice. Circ Res. 1995;76:907-914.
15. Pollick C, Hale S, Kloner R. Echocardiographic and cardiac Doppler assessment in mice. J Am Soc Echocardiogr. 1995;8:602-610.
16. Tanaka N, Dalton N, Mao L, Rockman H, Peterson K, Gottshall K, Hunter J, Chien K, Ross J. Transthoracic echocardiography in models of cardiac disease in the mouse. Circulation. 1996;8:1109-1117.
17. Soonpaa MH, Koh GY, Klug MG, Field LJ. Formation of nascent intercalated disks between grafted fetal cardiomyocytes and host myocardium. Science. 1994;264:98-101.
18. Greenfield A, Scott D, Pennisi D, Ehrmann I, Ellis P, Cooper L, Simpson E, Koopman P. An H-YDb epitope is encoded by a mouse Y chromosome gene. Nat Genet. 1996;14:474-478.
19. Li R-K, Mickle D, Weisel R, Mohabeer M, Zhang J, Rao V, Li G, Merante F, Jia Z-Q. Natural history of fetal rat cardiomyocytes transplanted into adult rat myocardial scar tissue. Circulation. 1997;96(suppl II):II-179-II-187.
20. Scorsin M, Marotte F, Sabri A, Le Dref O, Demirag M, Samuel J-L, Rappaport L, Menasché P. Can grafted cardiomyocytes colonize periinfarction myocardial areas? Circulation. 1996;94(suppl II):II-337-II-340.
21. Van Meter C, Claycomb W, Delcarpio J, Smith D, deGruiter H, Smart F, Ochsner J. Myoblast transplantation in the porcine model: a potential technique for myocardial repair. J Thorac Cardiovasc Surg. 1995;110: 1442-1448.
22. Leor J, Prentice H, Sartorelli V, Quinones M, Patterson M, Kedes L, Kloner R. Gene transfer and cell transplant: an experimental approach to repair a "broken heart." Cardiovasc Res. 1997;35:431-441.
23. Walgenbach K, Gratas C, Shestak K, Becker D. Ischaemia-induced expression of bFGF in normal skeletal muscle: a potential paracrine mechanism for mediating angiogenesis in ischaemic skeletal muscle. Nat Med. 1995;1:453-459.